1. Home
  2. CYCU vs HKPD Comparison

CYCU vs HKPD Comparison

Compare CYCU & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cycurion Inc.

CYCU

Cycurion Inc.

HOLD

Current Price

$1.67

Market Cap

7.8M

Sector

N/A

ML Signal

HOLD

HKPD

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares

N/A

Current Price

$0.63

Market Cap

6.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CYCU
HKPD
Founded
2017
2016
Country
United States
Hong Kong
Employees
N/A
27
Industry
Other Pharmaceuticals
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.8M
6.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CYCU
HKPD
Price
$1.67
$0.63
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
68.3K
32.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.54
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.16
$0.60
52 Week High
$7.13
$2.74

Technical Indicators

Market Signals
Indicator
CYCU
HKPD
Relative Strength Index (RSI) 41.17 39.02
Support Level $1.62 N/A
Resistance Level $2.91 $0.89
Average True Range (ATR) 0.13 0.05
MACD 0.04 0.00
Stochastic Oscillator 51.40 29.90

Price Performance

Historical Comparison
CYCU
HKPD

About CYCU Cycurion Inc.

Cycurion Inc. provides information technology security solutions through its subsidiaries. The Company continually strives to deliver top-notch services in risk management, cybersecurity, information assurance, systems engineering, and help desk solutions. The company generates the majority of its revenue from Advisory Consulting services, with small portion revenue generated from Managed Security Service Practice (MSSP) and Software as a Service (Saas).

About HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares

Cellyan Biotechnology Co Ltd formerly, Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.

Share on Social Networks: